North America And Europe Medical Foods Industry Overview
The North America and Europe medical foods market size was valued at USD 11.5 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 4.3% from 2021 to 2028.
Some of the drivers of the market are the rising geriatric population, the increasing prevalence of chronic diseases, and the growing focus of policymakers on the management of malnutrition. As per the data published by Population Reference Bureau in July 2019, the number of Americans aged 65 years or more is projected to double from an estimated 52.0 million in 2018 to 95.0 million by 2060.
Gather more insights about the market drivers, restrains and growth of the North America And Europe Medical Foods Market
The overall population age group share is anticipated to increase from 16.0% to 23.0%. Dietary management of chronic diseases and rare disorders is an emerging focus area for manufacturers of medical foods, which is also positively impacting the market growth. Patients suffering from chronic and infectious diseases such as tuberculosis, hepatitis, cancer, pneumonia, diabetes, and other neurological disorders develop nutritional deficiencies owing to adverse effects of the disease or drugs that are used for the treatment. Medical foods play a vital role in addressing these nutritional deficiencies as part of the overall treatment regimen, thus boosting their consumption.
The geriatric patient population suffering from neurological health disorders, such as stroke, multiple sclerosis, and dementia, which causes difficulty in swallowing, is the biggest target population for the market for medical foods in North America and Europe. This, in turn, has bolstered the adoption of medical foods for providing adequate nutritional support and mitigating the challenges of nutrition deficit among patients diagnosed with these conditions through enteral nutrition feeding tubes and oral nutrition supplements. Moreover, high unmet needs in developing North America and European countries with lucrative growth opportunities are expected to drive manufacturers to expand into these regions.
Browse through Grand View Research's Pharmaceuticals Industry Research Reports.
- Medical Foods Market - The global medical foods market size was valued at USD 21.2 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.2% from 2022 to 2030. The growing prevalence of communicable and non-communicable diseases and increasing effort for the dietary management of those diseases are anticipated to propel the market growth over the forecast years.
- Amino Acids Market - The global amino acids market size was valued at USD 26.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.4% during the forecast period of 2022 to 2030. The market is anticipated to be driven by the increasing demand for amino acids from the food, pharmaceutical, and nutraceutical industries.
North America And Europe Medical Foods Market Segmentation
Grand View Research, has segmented the North America and Europe medical foods market on the basis of route of administration, product type, payment scheme, application, sales channel, and region:
North America And Europe Medical Foods Route of Administration Outlook (Revenue, USD Million, 2016 - 2028)
- Oral
- Enteral
North America And Europe Medical Foods Product Type Outlook (Revenue, USD Million, 2016 - 2028)
- Pills
- Powders
- Others
North America And Europe Medical Foods Payment Scheme Outlook (Revenue, USD Million, 2016 - 2028)
- Reimbursed
- Diabetes
- Chronic Kidney Disease
- Other Applications
- Non-reimbursed
- Diabetes
- Chronic Kidney Disease
- Other Applications
North America And Europe Medical Foods Application Outlook (Revenue, USD Million, 2016 - 2028)
- Chronic Kidney Disease
- Minimal Hepatic Encephalopathy
- Chemotherapy Induced Diarrhoea
- Pathogen Related Infections
- Diabetic Neuropathy
- ADHD
- Depression
- Alzheimer's Disease
- Nutritional Deficiency
- Orphan Diseases
- Phenylketonuria
- Eosinophilic Esophagitis
- FPIES
- Others
- Wound Healing
- Chronic Diarrhea
- Constipation Relief
- Protein Booster
- Dysphagia
- Other Diseases
- Parkinson’s Disease
- Epilepsy
- Pain Management
- Other Cancer Related Treatments
North America And Europe Medical Foods Sales Channel Outlook (Revenue, USD Million, 2016 - 2028)
- Online Sales
- Retail Sales
- Institutional Sales
North America And Europe Medical Foods Regional Outlook (Revenue, USD Million, 2016 - 2028)
- North America
- Europe
Market Share Insights
- April 2021: Nestle acquired the core brands of The Bountiful Company for USD 5.75 billion.
- February 2020: According to the article published by Healthline, an estimated 48.0 million people are anticipated to be diagnosed with diabetes by 2050.
Key Companies profiled:
Some prominent players in the North America And Europe medical foods market include
- Danone
- Nestle
- Targeted Medical Pharma, Inc.
- Abbott
- Primus Pharmaceuticals, Inc.
- Medtrition, Inc.
- Mead Johnson & Company, LLC
- Fresenius Kabi AG
Order a free sample PDF of the North America And Europe Medical Foods Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
